C-Reactive Protein (CRP) tests are blood tests that measure C-Reactive Protein levels. C-reactive protein (CRP) is a protein generated by the liver, and its levels rise when there is inflammation or tissue injury in the body. Infections and disorders that induce inflammation, such as certain types of malignancies, cardiovascular diseases, arthritis, and others, are detected and tracked using C-reactive testing. C-reactive protein tests predict the chances of a person having a heart attack or a stroke. The rising prevalence of cardiovascular disorders, as well as the sheer amount of tests necessary, are the primary drivers for the market growth.
MARKET SCOPE
The Global C- Reactive Protein Testing Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the c- reactive protein testing market with detailed market segmentation by assay type, detection range, disease area and end-use. The report provides key statistics on the market status of the leading c- reactive protein testing market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on assay-type the market is segmented as, immunoturbidimetric assay, ELISA, chemluminescence immunoassay and others.
- Based on detection range the market is segmented as, HS-CRP, convestional CRP and CCRP.
- Based on disease area the market is segmented as, cardiovascular diseases, cancer, RA, endometriosis, IBD, others.
- Based on end-use the market is segmented as, clinics, hospitals, laboratories, others.
MARKET DYNAMICS
Drivers:
- Increasing prevalence of cardiovascular diseases across the globe the the key driving factor for the market growth.
- Growing prevalence of other diseases such as cancers, diabetes, acute infections also expected to spur the market growth.
- Extensive R&D development activities conducted on different applications of CRP testing is expected to create significant growth opportunities for the market.
Restraints:
- However, dearth of skilled professionals and lack of awareness about CRP testing are expected to restrain market growth.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The c- reactive protein testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the c- reactive protein testing market in these regions.
IMPACT OF COVID-19 ON C- REACTIVE PROTEIN TESTING MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the c- reactive protein testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from c- reactive protein testing market are anticipated to lucrative growth opportunities in the future with the rising demand for c- reactive protein testing in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the c- reactive protein testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abcam Plc
- Bio-Techne
- F. Hoffmann-La Roche Ltd
- Randox Laboratories Ltd
- Merck KGaA
- Thermo Fisher Scientific Inc
- LifeSpan BioSciences, Inc
- Abaxis, Inc.
- Quest Diagnostics
- Siemens Healthineers